Clinical practice guideline: Ménière's disease

GJ Basura, ME Adams, A Monfared… - … –Head and Neck …, 2020 - Wiley Online Library
Objective Ménière's disease (MD) is a clinical condition defined by spontaneous vertigo
attacks (each lasting 20 minutes to 12 hours) with documented low‐to midfrequency …

Treatment of Meniere's disease

JD Sharon, C Trevino, MC Schubert… - Current treatment options …, 2015 - Springer
Opinion statement Diagnosis of Menière's disease is made with a characteristic patient
history, including discrete episodes of vertigo lasting 20 min or longer, accompanied by …

The pharmacological management of vertigo in Meniere disease

JM Espinosa-Sanchez… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction The term Meniere disease (MD) gathers a set of rare diseases
involving the inner ear characterized by episodic vertigo associated with fluctuating auditory …

A state-of-the-art analysis of pharmacological delivery and artificial intelligence techniques for inner ear disease treatment

W Li, N Zheng, Q Zhou, MS Alqahtani… - Environmental …, 2023 - Elsevier
Over the last several decades, both the academic and therapeutic fields have seen
significant progress in the delivery of drugs to the inner ear due to recent delivery methods …

Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of …

SK Plontke, A Liebau, E Lehner, D Bethmann… - Frontiers in …, 2022 - frontiersin.org
Background Intratympanic injections of glucocorticoids have become increasingly common
in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL). However, due to …

Management of intractable M énière's disease after intratympanic injection of Gentamicin

YC Rah, JJ Han, J Park, BY Choi, JW Koo - The Laryngoscope, 2015 - Wiley Online Library
Objectives/Hypothesis 1) To evaluate the efficacy of, and problems with, intratympanic
gentamicin injection (ITG) in medically intractable definite Ménière's disease (MD) and …

Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss

SK Plontke, A Glien, T Rahne, K Mäder… - Otology & …, 2014 - journals.lww.com
Objective To evaluate the feasibility and hearing outcome of a biocompatible degradable
dexamethasone releasing implant for continuous drug delivery to the round window …

Round window perfusion dynamics: implications for intracochlear therapy

SN Bowe, A Jacob - Current opinion in otolaryngology & head and …, 2010 - journals.lww.com
Round window perfusion dynamics: implications for intracochl... : Current Opinion in
Otolaryngology & Head and Neck Surgery Round window perfusion dynamics: implications for …

Management of ménière's disease: how does the coexistence of vestibular migraine affect outcomes?

CH Shin, Y Kim, MH Yoo, TS Kim, JW Park… - Otology & …, 2019 - journals.lww.com
Objective: To report the incidence of vestibular migraine (VM) in patients with Ménière's
disease (MD) and investigate whether management outcomes of MD differ by the …

Inner ear therapeutics: an overview of middle ear delivery

J Patel, M Szczupak, S Rajguru, C Balaban… - Frontiers in cellular …, 2019 - frontiersin.org
There are a variety of methods to access the inner ear and many of these methods depend
on utilizing the middle ear as a portal. In this approach the middle ear can be used as a …